FBInvestor
Stocks / Capricor Therapeutics Inc
Institutional Ownership

Capricor Therapeutics Inc

CUSIP 14070B309COM NEWCAPRQ1 2026

13D / 13G Filings
17
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
18.9%
Max % of class reported
Institutional Holders
171
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

17 filings · latest Feb 26, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 26, 2026Suvretta Capital Management, LLC13G6.6%3.42MSEC
2Feb 17, 2026Highbridge Capital Management, LLC13G/A2.3%1.20MSEC
3Jan 26, 2026Tang Capital Management, LLC13G6.6%3.40MSEC
4Oct 30, 2025The Vanguard Group13G/A4.8%2.21MSEC
5Jul 29, 2025The Vanguard Group13G5.0%2.31MSEC
6Apr 30, 2025The Vanguard Group13G/A5.0%2.26MSEC
7Feb 5, 2025Blackrock, Inc.13G/A6.5%2.97MSEC
8Jan 30, 2025The Vanguard Group13G5.0%2.28MSEC
9Nov 12, 2024Blackrock, Inc.13G5.4%1.75MSEC
10Nov 8, 2024Highbridge Capital Management LLC13G/A6.5%2.79MSEC

7 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Capricor Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Suvretta Capital Management, LLC3.82M$116.09M
2Blackrock, Inc.3.42M$104.02M
3Tang Capital Management LLC3.40M$103.36M
4State Street Corp2.18M$66.33M
5Ra Capital Management, L.P.1.51M$45.84M
6Geode Capital Management, LLC1.12M$34.00M
7Goldman Sachs Group Inc912.0K$27.72M
8Jones Hill Capital LP909.2K$27.64M
9Point72 Asset Management, L.P.821.2K$24.96M
10Fmr LLC772.6K$23.49M